[go: up one dir, main page]

DE69107226D1 - Verwendung von Tumornekrosefaktor. - Google Patents

Verwendung von Tumornekrosefaktor.

Info

Publication number
DE69107226D1
DE69107226D1 DE69107226T DE69107226T DE69107226D1 DE 69107226 D1 DE69107226 D1 DE 69107226D1 DE 69107226 T DE69107226 T DE 69107226T DE 69107226 T DE69107226 T DE 69107226T DE 69107226 D1 DE69107226 D1 DE 69107226D1
Authority
DE
Germany
Prior art keywords
necrosis factor
tumor necrosis
disease
demyelinatig
uveitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69107226T
Other languages
English (en)
Other versions
DE69107226T2 (de
Inventor
Yoshiki Otsuka
Kazuyoshi Hori
Hiroshi Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2056734A external-priority patent/JPH03261726A/ja
Priority claimed from JP2056736A external-priority patent/JPH03261725A/ja
Priority claimed from JP2056735A external-priority patent/JPH03261724A/ja
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Publication of DE69107226D1 publication Critical patent/DE69107226D1/de
Application granted granted Critical
Publication of DE69107226T2 publication Critical patent/DE69107226T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Telephonic Communication Services (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69107226T 1990-03-09 1991-03-08 Verwendung von Tumornekrosefaktor. Expired - Fee Related DE69107226T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2056734A JPH03261726A (ja) 1990-03-09 1990-03-09 ぶどう膜炎治療用医薬組成物
JP2056736A JPH03261725A (ja) 1990-03-09 1990-03-09 移植片対宿主の疾患治療用医薬組成物
JP2056735A JPH03261724A (ja) 1990-03-09 1990-03-09 脱髄性疾患治療用医薬組成物

Publications (2)

Publication Number Publication Date
DE69107226D1 true DE69107226D1 (de) 1995-03-23
DE69107226T2 DE69107226T2 (de) 1995-05-24

Family

ID=27296018

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4107554A Withdrawn DE4107554A1 (de) 1990-03-09 1991-03-08 Methoden zur behandlung von demyelinisierenden erkrankungen, uveitis oder graft-versus-host-erkrankungen
DE69107226T Expired - Fee Related DE69107226T2 (de) 1990-03-09 1991-03-08 Verwendung von Tumornekrosefaktor.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4107554A Withdrawn DE4107554A1 (de) 1990-03-09 1991-03-08 Methoden zur behandlung von demyelinisierenden erkrankungen, uveitis oder graft-versus-host-erkrankungen

Country Status (11)

Country Link
US (1) US5190750A (de)
EP (1) EP0445894B1 (de)
AT (1) ATE118221T1 (de)
AU (1) AU633196B2 (de)
CA (1) CA2037831C (de)
DE (2) DE4107554A1 (de)
DK (1) DK0445894T3 (de)
ES (1) ES2067842T3 (de)
FR (1) FR2659235A1 (de)
GB (1) GB2241891B (de)
GR (1) GR3015840T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08500823A (ja) * 1992-08-17 1996-01-30 オートイミューン インク レトロウィルス関連神経疾患のバイスタンダー抑制
CA2187345A1 (en) * 1994-04-08 1995-10-19 Howard L. Weiner Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
ATE365800T1 (de) * 1998-05-15 2007-07-15 Genentech Inc Therapeutische verwendungen von il-17 homologe polypeptide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292727A (ja) * 1986-06-12 1987-12-19 Dainippon Pharmaceut Co Ltd 癌壊死因子を有効成分とする鎮痛・消炎剤
JPS6330426A (ja) * 1986-07-25 1988-02-09 Mitsubishi Chem Ind Ltd 自己免疫性疾患治療薬
DE3631413A1 (de) * 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US4963354A (en) * 1987-01-21 1990-10-16 Genentech, Inc. Use of tumor necrosis factor (TNF) as an adjuvant
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
AU2844889A (en) * 1988-01-22 1989-07-27 Collagen Corporation Method for suppressing the growth of normal and cancer cells
DE3839639A1 (de) * 1988-11-24 1990-05-31 Basf Ag Verwendung von tnf bei der behandlung von hautkrankheiten
CA2003981C (en) * 1988-12-27 2000-06-13 Hiroshi Ishimaru Pharmaceutical compositions and use thereof in the treatment of psoriasis

Also Published As

Publication number Publication date
ES2067842T3 (es) 1995-04-01
GB2241891B (en) 1994-05-25
DE4107554A1 (de) 1991-10-10
AU7281091A (en) 1991-09-12
GR3015840T3 (en) 1995-07-31
AU633196B2 (en) 1993-01-21
GB9104927D0 (en) 1991-04-24
EP0445894A2 (de) 1991-09-11
ATE118221T1 (de) 1995-02-15
CA2037831C (en) 1997-01-21
US5190750A (en) 1993-03-02
GB2241891A (en) 1991-09-18
EP0445894B1 (de) 1995-02-08
DE69107226T2 (de) 1995-05-24
FR2659235A1 (fr) 1991-09-13
CA2037831A1 (en) 1991-09-10
DK0445894T3 (da) 1995-04-03
EP0445894A3 (en) 1992-01-02

Similar Documents

Publication Publication Date Title
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE69706825D1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
ATE165514T1 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
ATE211729T1 (de) Therapeutisch wirksame verbindungen
CA2041417A1 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
DK658889A (da) Farmaceutisk praeparat til brug ved behandling af psoriasis
DE69107226D1 (de) Verwendung von Tumornekrosefaktor.
CA2027814A1 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
DK0523013T3 (da) Anvendelse af benzimidazolin-2-oxo-1-carboxylsyrederivater ved behandling af organiske mentale sygdomme
FI890173L (fi) Isoxazoler med nootropisk verkan.
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono
RU96124097A (ru) Активатор дифференцировки нервных клеток
RU93004721A (ru) Сульфонамидные соединения, способ их получения и фармацевтическая композиция

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee